Ovarian Cancer Clinical Trials

Review the ovarian cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 300

Universal Genetic Testing for Cancer Risk Reduction: A Prospective Interventional Pilot Study
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Vaginal Metabolome Healthy Volunteer Protocol
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Responses to Genetic Risk Modifier Testing among Women with BRCA1/2 Mutations
Status: Active
Location: 7 locations
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Status: Active
Location: 7 locations
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Status: Active
Location: 2 locations
The Role of Mitochondrial Bioenergetics in Resilience in Older Adults with Gynecologic Cancer Receiving Cancer Reductive Treatment
Status: Active
Location: 2 locations
Social Health, Activity Behaviors, and Quality of Life among Young Adult Cancer Survivors
Status: Active
Location: 2 locations
Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer (PROMISE Study)
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Understanding the Experience of Ovarian Cancer-Life after Diagnosis, UNTOLD Study
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
The BHFS Study (Better, Harder, Faster, Stronger): Does Neoadjuvant Chemotherapy Improve Fitness for Surgery?
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Clinical Pre-screening Protocol for Ovarian Cancer
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Prospective Study to Assess a Diagnostic Aid for Cancer
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Data Collection for Patients with Low Grade Ovarian or Peritoneal Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Northwestern Ovarian Cancer Early Detection and Prevention Program
Status: Active
Location: Northwestern University, Chicago, Illinois
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
International Ovarian & Testicular Stromal Tumor Registry
Status: Active
Location: Dana-Farber Cancer Institute, Boston, Massachusetts
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients with Cancers, CHANCES Study
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Rapid Autopsy and Procurement of Cancer Tissue
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Breast Cancer Liquid Biopsy Trial
Status: Active
Location: See ClinicalTrials.gov
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Status: Enrolling by Invitation
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Paclitaxel Monitoring in Patients with Solid Tumors
Status: Temporarily Closed to Accrual
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov